Jim Cramer on Medtronic (MDT): “I Think That Everything They…

Jim Cramer on Medtronic (MDT): “I Think That Everything They…

Insider Monkey – Free Hedge Fund and Insider Trading Data (Syeda Seirut Javed)

Medtronic plc (NYSE:MDT) was featured on Mad Money as Jim Cramer shared his take on the stock amid a sliding macro environment. When a caller asked about the stock, Cramer said:

I have to tell you, I was surprised that Medtronic got back down to the high $80s. I think that everything they’ve been doing lately is right. I think you’ve got a good one. By the way, it’s 15 times earnings. That’s very inexpensive. I would buy more… I know it sounds like you’re just averaging down into oblivion, but I think it’s a great level.

Stock market data. Photo by Photo by Alesia Kozik


Medtronic plc (NYSE:MDT) develops and sells device-based medical therapies to healthcare systems, physicians, and patients. The company provides specialized products, including cardiac pacemakers, surgical instruments, robotic-assisted surgery platforms, and a number of diabetes management systems.

[im-yf-promo]

While we acknowledge the potential of MDT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

[/im-yf-promo]

While we acknowledge the risk and potential of MDT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MDT and that has 10,000% upside potential, check out our report about this cheapest AI stock.


READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years. 

Disclosure: None. Follow Insider Monkey on Google News.

Generated by RSStT. The copyright belongs to the original author.

Source

Report Page